BRWD3 antibody (Bromodomain and WD Repeat Domain Containing 3) (Cy3)

Details for Product anti-BRWD3 Antibody No. ABIN1411353, Supplier: Log in to see
Antigen
  • CG18670
  • CG31132
  • CG6400
  • Dmel\\CG31132
  • anon-WO0118547.520
  • anon-WO0118547.620
  • dBRWD3
  • l(3)05842
  • l(3)s5349
  • ram
  • BRODL
  • MRX93
  • Brodl
  • D030064D06Rik
  • Gm596
  • RGD1559445
  • bromodomain and WD repeat domain containing 3
  • CG31132 gene product from transcript CG31132-RA
  • PH-interacting protein
  • BRWD3
  • LOC412406
  • Brwd3
Reactivity
Human, Mouse (Murine), Rat (Rattus)
24
20
15
Host
Rabbit
24
Clonality
Polyclonal
Conjugate
This BRWD3 antibody is conjugated to Cy3
1
1
1
1
1
1
1
1
1
1
1
1
1
Application
Immunofluorescence (Paraffin-embedded Sections) (IF (p))
12
12
9
9
6
2
2
Options
Supplier
Log in to see
Supplier Product No.
Log in to see
Immunogen KLH conjugated synthetic peptide derived from human BRWD3
Isotype IgG
Purification Purified by Protein A.
Plasmids, Primers & others Plasmids, Primers & others BRWD3 products on genomics-online (e.g. as negative or positive controls)
Antigen
Alternative Name Brwd3 (BRWD3 Antibody Abstract)
Background

Members of the WD repeat protein family are involved in a variety of cellular processes, including cell cycle progression, signal transduction, apoptosis and gene regulation. BRWD3 (bromodomain and WD repeat-containing protein 3) is a 1,802 amino acid protein expressed in fetal liver and most adult tissues. Existing as five alternatively spliced isoforms, BRWD3 contains two bromo domains, nine WD repeats and is thought to play a role in transcription by modifying chromatin. Mutations in the gene encoding BRWD3 are the cause of mental retardation X-linked type 93 (MRX93), which is also known as mental retardation X-linked with macrocephaly (XLMR). MRX93 is characterized by mild intellectual disability, macrocephaly, a prominent forehead and large cupped ears.

Synonyms: BRODL, Bromo domain containing protein disrupted in leukemia, Bromodomain and WD repeat domain containing 3, Novel WD repeat domain protein, BRWD3_HUMAN.

Application Notes IF(IHC-P) 1:50-200
Restrictions For Research Use only
Format Liquid
Concentration 1 μg/μL
Buffer Aqueous buffered solution containing 1 % BSA, 50 % glycerol and 0.09 % sodium azide.
Preservative Sodium azide
Precaution of Use This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
Storage 4 °C
Storage Comment Store at 4°C
Expiry Date 12 months
Did you look for something else?